Vireo growth sees $25k stock purchase by Chicago Atlantic Credit

Published 09/04/2025, 02:54
Vireo growth sees $25k stock purchase by Chicago Atlantic Credit

In a recent transaction, Chicago Atlantic Credit Opportunities, LLC, a significant shareholder in Vireo Growth Inc. (NASDAQ:VREO), acquired 60,000 Subordinate Voting Shares of the company. The shares were purchased at a weighted average price of $0.4193 per share, totaling approximately $25,158. According to InvestingPro data, this purchase comes as the stock has fallen over 24% in the past week, with the current market capitalization standing at $139 million. The transaction occurred on April 4, 2025, and was disclosed in a Form 4 filing with the Securities and Exchange Commission.

This acquisition adds to Chicago Atlantic's existing holdings, bringing their total direct ownership to 11,206,278 shares. The firm has been involved in previous transactions with Vireo Growth, as noted in their filings.

The purchase price for the shares ranged between $0.4018 and $0.44, according to the filing. The transaction highlights Chicago Atlantic's continued interest in Vireo Growth, a company classified under pharmaceutical preparations. Based on InvestingPro's Fair Value analysis, the stock appears undervalued at current levels. Unlock 6 additional ProTips and comprehensive financial analysis with an InvestingPro subscription.

In other recent news, Vireo Growth Inc. reported a 15.4% increase in full-year revenue, reaching $99.4 million, with fourth-quarter revenue up 3.5% to $25 million. Despite these gains, the company experienced a net loss of $15.7 million in the fourth quarter, primarily due to one-time transaction expenses. Vireo Growth is focusing on strategic initiatives, including a new cultivation facility and expansion into adult-use sales, which are expected to contribute to a transformative year ahead. The company ended the year with a strong cash position of $91.6 million, following an $81 million private placement. Vireo Growth anticipates significant contributions from its New York facility in 2025, with projections indicating continued revenue growth. The company is also planning mergers expected to close in 2025, pending regulatory and shareholder approvals. Analysts have expressed interest in the timeline for Vireo's new Minnesota facility, which is expected to be completed within 2025. Additionally, Vireo Growth is planning to divest a portion of its New York assets while focusing on producing high-end cannabis flower.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.